Medico Remedies Past Earnings Performance
Past criteria checks 3/6
Medico Remedies has been growing earnings at an average annual rate of 37.3%, while the Pharmaceuticals industry saw earnings growing at 14.8% annually. Revenues have been growing at an average rate of 9.6% per year. Medico Remedies's return on equity is 14.6%, and it has net margins of 5.3%.
Key information
37.3%
Earnings growth rate
37.3%
EPS growth rate
| Pharmaceuticals Industry Growth | 17.5% |
| Revenue growth rate | 9.6% |
| Return on equity | 14.6% |
| Net Margin | 5.3% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Medico Remedies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 1,316 | 70 | 59 | 0 |
| 30 Sep 23 | 1,407 | 78 | 59 | 0 |
| 30 Jun 23 | 1,388 | 82 | 58 | 0 |
| 31 Mar 23 | 1,404 | 72 | 58 | 0 |
| 31 Dec 22 | 1,447 | 75 | 61 | 0 |
| 30 Sep 22 | 1,360 | 63 | 65 | 0 |
| 30 Jun 22 | 1,251 | 51 | 57 | 0 |
| 31 Mar 22 | 1,210 | 48 | 60 | 0 |
| 31 Dec 21 | 1,191 | 33 | 60 | 0 |
| 30 Sep 21 | 1,194 | 28 | 55 | 0 |
| 30 Jun 21 | 1,207 | 19 | 51 | 0 |
| 31 Mar 21 | 1,224 | 26 | 49 | 0 |
| 31 Dec 20 | 1,149 | 25 | 45 | 0 |
| 30 Sep 20 | 1,074 | 25 | 41 | 0 |
| 30 Jun 20 | 980 | 20 | 40 | 0 |
| 31 Mar 20 | 886 | 16 | 39 | 0 |
| 31 Dec 19 | 938 | 18 | 36 | 0 |
| 30 Sep 19 | 990 | 19 | 33 | 0 |
| 30 Jun 19 | 984 | 17 | 34 | 0 |
| 31 Mar 19 | 977 | 16 | 34 | 0 |
| 31 Dec 18 | 855 | 14 | -13 | 0 |
| 30 Sep 18 | 732 | 13 | 40 | 0 |
| 30 Jun 18 | 671 | 12 | 40 | 0 |
| 31 Mar 18 | 610 | 12 | 41 | 0 |
| 31 Mar 17 | 544 | 16 | 45 | 0 |
| 31 Mar 16 | 667 | 11 | 100 | 0 |
| 31 Mar 15 | 510 | 8 | 89 | 0 |
| 31 Mar 14 | 449 | 6 | 81 | 0 |
Quality Earnings: 540937 has high quality earnings.
Growing Profit Margin: 540937's current net profit margins (5.3%) are higher than last year (5.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 540937's earnings have grown significantly by 37.3% per year over the past 5 years.
Accelerating Growth: 540937's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 540937 had negative earnings growth (-7.4%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (23.8%).
Return on Equity
High ROE: 540937's Return on Equity (14.6%) is considered low.